The CDC recommends a single dose of any FDA-approved RSV vaccine for all adults ages 75 years and older, as well as for 60- ...

Wisconsin DHS Respiratory Disease Epidemiologist Thomas Haupt told the Journal Sentinel in an email the department's most ...

State Public Health Data shows flu and RSV hospitalizations are rising. Officials say this season is similar to pre-COVID ...

GSK and Pfizer's respiratory syncytial virus (RSV) vaccines will carry warnings that they can increase the risk of developing ...

The CDC reports that influenza A, COVID-19, norovirus, and RSV are on the rise this winter, with symptoms such as fever, ...

The FDA will require GSK and Pfizer to include on the label of their respiratory syncytial virus (RSV) vaccines a warning ...

The Covid-19 positivity rate has also seen a rise to 7.1% this past week, versus the 5.5% figure for the past four weeks.

FDA updates safety labels for Pfizer's Abrysvo and GSK's Arexvy RSV vaccines, citing increased Guillain-Barré syndrome risk.

There has been an uptick in cases of norovirus (or “winter vomiting disease”), since it’s more common in the winter.

He also articulated a very specific doctrine about the role of an FDA commissioner, one that is limited in its power and ...

For immunocompromised individuals, antibody response to respiratory syncytial virus (RSV) vaccines is heterogeneous an ...

Following a sharp rise in cases of walking pneumonia among Canadian children, rates of the infection seem to be dropping — ...